Astria Therapeutics
Why Robinhood?
You can watch ATXS and buy or sell other stocks, ETFs, and their options commission-free!About ATXS
Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway.
ATXS Key Statistics
Stock Snapshot
Astria Therapeutics(ATXS) stock is priced at $12.58, giving the company a market capitalization of 709.95M. It carries a P/E multiple of -5.85.
On 2026-02-06, Astria Therapeutics(ATXS) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 581.79K.
The stock's 52-week range extends from a low of $3.56 to a high of $13.29.
The stock's 52-week range extends from a low of $3.56 to a high of $13.29.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.